Product Information
TIAGABINE HCL 16 MG TABLET is a generic product labeled by Novadoz Pharmaceuticals LLC, priced at $6.0268 per EA under NDC 72205008730. Its NADAC has been published 78 times since Nov 20, 2024.
FDA first approved this application on Nov 16, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
16 mg/1
Manufacturer
Novadoz Pharmaceuticals LLCNDC
72205008730
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
5/21/2025
Active Ingredients
TIAGABINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA214816FDA Approved
11/16/2021
TE Code
AB
On Market Since
11/23/2021
Pharmacological Classes
Price Statistics
The NADAC for TIAGABINE HCL 16 MG TABLET has been published 78 times since Nov 20, 2024, and over the history we have for it it has declined 7.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $6.0268 per EA |
|---|---|
| All-time high | $6.4888 (Mar 12, 2025) |
| All-time low | $6.0268 (Apr 23, 2025) |
| 52-week high | $6.0268 |
| 52-week low | $6.0268 |
| Median price | $6.0268 |
| Average price | $6.1423 |
| Largest weekly change | -3.7% (Apr 23, 2025) |
| Weeks tracked | 78 |
| Tracking since | Nov 20, 2024 |
1W
N/A
1M
N/A
3M
N/A
6M
0.0%
1Y
0.0%
3Y
N/A
5Y
N/A
All
-7.1%
Last surveyed May 13, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of TIAGABINE HCL 16 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for TIAGABINE HCL 16 MG TABLET, manufactured by Novadoz Pharmaceuticals LLC, is $6.0268 per EA (NDC 72205008730), effective May 13, 2026.
How has the price of TIAGABINE HCL 16 MG TABLET changed over time?
Over the history we have for it, the NADAC for TIAGABINE HCL 16 MG TABLET has declined 7.1%. It has been tracked across 78 weekly CMS publications since Nov 20, 2024.
What are the highest and lowest recorded NADAC prices for TIAGABINE HCL 16 MG TABLET?
Since Nov 20, 2024, the NADAC for TIAGABINE HCL 16 MG TABLET has ranged from a low of $6.0268 (Apr 23, 2025) to a high of $6.4888 (Mar 12, 2025), with a median of $6.0268 per EA.
Are there cheaper alternatives to TIAGABINE HCL 16 MG TABLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as TIAGABINE HCL 16 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures TIAGABINE HCL 16 MG TABLET?
TIAGABINE HCL 16 MG TABLET (NDC 72205008730) is labeled by Novadoz Pharmaceuticals LLC, and CMS classifies it as a generic product.